As of 2026-04-05, the Relative Valuation of Xlife Sciences AG (XLS.SW) is 183.29 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 19.70 CHF, the upside of Xlife Sciences AG based on Relative Valuation is 830.4%.
The range of the Relative Valuation is 104.50 - 261.91 CHF.
| Range | Selected | |
| Trailing P/E multiples | 24.0x - 29.2x | 26.2x |
| Forward P/E multiples | 28.9x - 35.2x | 34.0x |
| Fair Price | 104.50 - 261.91 | 183.29 |
| Upside | 430.5% - 1229.5% | 830.4% |
| Date | P/E |
| 2026-04-02 | 4.53 |
| 2026-04-01 | 4.60 |
| 2026-03-31 | 4.58 |
| 2026-03-30 | 4.72 |
| 2026-03-27 | 4.72 |
| 2026-03-26 | 4.92 |
| 2026-03-25 | 5.01 |
| 2026-03-24 | 4.88 |
| 2026-03-23 | 5.01 |
| 2026-03-20 | 5.06 |
| 2026-03-19 | 4.90 |
| 2026-03-18 | 5.15 |
| 2026-03-17 | 5.13 |
| 2026-03-16 | 5.29 |
| 2026-03-13 | 5.52 |
| 2026-03-12 | 5.29 |
| 2026-03-11 | 5.61 |
| 2026-03-10 | 5.08 |
| 2026-03-09 | 4.85 |
| 2026-03-06 | 5.08 |
| 2026-03-05 | 5.18 |
| 2026-03-04 | 5.13 |
| 2026-03-03 | 4.97 |
| 2026-03-02 | 5.08 |
| 2026-02-27 | 5.18 |
| 2026-02-26 | 5.22 |
| 2026-02-25 | 4.88 |
| 2026-02-24 | 5.13 |
| 2026-02-23 | 5.25 |
| 2026-02-20 | 4.88 |
| 2026-02-19 | 4.92 |
| 2026-02-18 | 5.01 |
| 2026-02-17 | 4.69 |
| 2026-02-16 | 4.88 |
| 2026-02-13 | 4.72 |
| 2026-02-12 | 4.85 |
| 2026-02-11 | 4.88 |
| 2026-02-10 | 4.88 |
| 2026-02-09 | 5.06 |
| 2026-02-06 | 4.65 |
| 2026-02-05 | 4.92 |
| 2026-02-04 | 4.83 |
| 2026-02-03 | 4.74 |
| 2026-02-02 | 4.90 |
| 2026-01-30 | 5.29 |
| 2026-01-29 | 5.08 |
| 2026-01-28 | 5.41 |
| 2026-01-27 | 5.41 |
| 2026-01-26 | 5.20 |
| 2026-01-23 | 5.18 |